|
ATF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.0008996943518E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89930310262798E-11 |
| Normal-vs-Stage2 |
2.31589999999393E-05 |
| Normal-vs-Stage3 |
4.462900E-03 |
| Normal-vs-Stage4 |
6.020300E-02 |
| Stage1-vs-Stage2 |
6.365600E-01 |
| Stage1-vs-Stage3 |
8.645600E-02 |
| Stage1-vs-Stage4 |
5.587600E-01 |
| Stage2-vs-Stage3 |
4.023600E-01 |
| Stage2-vs-Stage4 |
8.427400E-01 |
| Stage3-vs-Stage4 |
6.872400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.326500186418E-10 |
| Normal-vs-AfricanAmerican |
1.48769999985809E-07 |
| Normal-vs-Asian |
5.644200E-04 |
| Caucasian-vs-AfricanAmerican |
8.871000E-01 |
| Caucasian-vs-Asian |
7.042600E-01 |
| AfricanAmerican-vs-Asian |
6.832600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.882916541746E-12 |
| Normal-vs-Female |
7.277700E-03 |
| Male-vs-Female |
1.570620E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55940999999604E-05 |
| Normal-vs-Extreme_Weight |
2.19579909810363E-12 |
| Normal-vs-Obese |
2.06339999999638E-05 |
| Normal-vs-Extreme_Obese |
3.96309999994848E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.891580E-01 |
| Normal_Weight-vs-Obese |
4.105000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.718200E-01 |
| Extreme_Weight-vs-Obese |
7.722200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.636600E-01 |
| Obese-vs-Extreme_Obese |
2.625600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.525600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.55719999620041E-08 |
| Normal-vs-Age(61-80Yrs) |
2.25609531057103E-11 |
| Normal-vs-Age(81-100Yrs) |
6.87269996468842E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.018190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.774400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.433700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.976100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.587600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08166817117217E-12 |
| Normal-VS-Type2 PRCC |
1.69770000002512E-06 |
| Normal-VS-KIRP CIMP |
6.671600E-01 |
| Normal-VS-Unclassified PRCC |
1.404120E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.034400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.756500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.920600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.554500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.802400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.468960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64590016563204E-10 |
| Normal-vs-N1 |
2.505600E-01 |
| Normal-vs-N2 |
8.228000E-01 |
| N0-vs-N1 |
1.170200E-02 |
| N0-vs-N2 |
3.220800E-01 |
| N1-vs-N2 |
8.421000E-01 |
|
|
